| Promoter analysis of tumor suppressor gene PTEN: identification of minimum promoter region. | None |
| Reversible inactivation of the tumor suppressor PTEN by H2O2. | None |
| Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity. | None |
| Negative feedback regulation of the tumor suppressor PTEN by phosphoinositide-induced serine phosphorylation. | None |
| Knockout mice lacking Pten show abnormalities in tumor suppression, immune function and embryo development. | None |
| The inducible expression of the tumor suppressor gene PTEN promotes apoptosis and decreases cell size by inhibiting the PI3K/Akt pathway in Jurkat T cells. | None |
| Phosphorylation-regulated cleavage of the tumor suppressor PTEN by caspase-3: implications for the control of protein stability and PTEN-protein interactions. | None |
| tumor suppressor PTEN, inhibits the interaction of CH-ILKBP with ILK | None |
| Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-alpha/nuclear factor-kappaB (NF-kappaB)-inducing kinase/NF-kappaB pathway is linked to a default IkappaB-alpha autoregulatory loop. | None |
| Perlecan-induced suppression of smooth muscle cell proliferation is mediated through increased activity of the tumor suppressor PTEN. | None |
| Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase. | None |
| results show that PTEN can inhibit cell migration through its C2 domain, independent of its lipid phosphatase activity; ability of PTEN to control cell migration through its C2 domain is likely to be an important feature of its tumor suppressor activity | None |
| the tumor suppressor PTEN has a profound effect on differentiation by affecting several pathways involved in nerve growth factor signaling | None |
| a tumour suppressor candidate protein binds to extreme C-terminal region of PTEN and regulates PTEN protein turnover [review] | None |
| One common way of stimulating the 1-Phosphatidylinositol 3-Kinase kinase pathway occurs through inactivation of the PTEN tumor suppressor | None |
| We found that indomethacin and NS-398 treatment significantly upregulated expression of the tumor suppressor gene, PTEN. | None |
| increased levels of Trx-1 in human tumors could lead to functional inhibition of PTEN tumor suppressor activity providing an additional mechanism for tumorigenesis with loss of PTEN activity | None |
| Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein. | None |
| Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. | None |
| Analysis of phosphatase and tensin homolog tumor suppressor interacting proteins by in vitro and in silico proteomics. | None |